P3 Health Partners Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.5B | $1.5B | $1.3B | $1.0B | — |
| Operating expenses | $1.7B | $1.8B | $1.4B | $2.6B | — |
| Operating income | -$270.3M | -$320.7M | -$167.9M | -$1.6B | — |
| Pretax income | -$321.1M | -$306.0M | -$183.7M | -$1.6B | — |
| Income tax expense | $2.0M | $4.4M | $2.7M | $1.9M | — |
| Net income | -$147.9M | -$135.8M | -$57.8M | -$270.1M | — |
| Balance Sheet | |||||
| Cash and equivalents | $25.0M | $38.8M | $36.3M | $17.5M | $140.5M |
| Current assets | $133.1M | $184.1M | $166.0M | $100.7M | $199.9M |
| Total assets | $656.6M | $783.4M | $861.0M | $876.6M | $2.4B |
| Current liabilities | $545.3M | $496.4M | $299.4M | $241.7M | $198.8M |
| Total liabilities | $796.9M | $633.9M | $427.3M | $353.9M | $299.9M |
| Total debt | $273.4M | $184.1M | $108.3M | $95.0M | $80.0M |
| Stockholders' equity | -$155.2M | $75.9M | $142.1M | $5.9M | $273.6M |
| Cash Flow Statement | |||||
| Cash from operations | -$91.2M | -$110.1M | -$76.0M | -$126.0M | — |
| Depreciation and amortization | $2.2M | $2.4M | $2.3M | $2.4M | — |
| Stock-based compensation | $5.6M | $5.8M | $6.0M | $19.4M | — |
| Capital expenditure | — | $0 | $1.8M | $2.2M | — |
| Free cash flow | — | -$110.1M | -$77.9M | -$128.3M | — |
| Impairments | — | — | $0 | $1.3B | — |
Shares outstanding 7.2M · Free float 76.2%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.